New Drug Application

FDA Approves Momentous New Indications for Xarelto

Submitted by Dr Marc Macera on Mon, 12/10/2012 - 14:12

Last month the U.S. Food and Drug Administration (FDA) approved rivaroxaban (Xarelto), a factor Xa inhibitor, for the treatment and prevention of acute deep vein thrombosis (DVT) and pulmonary embolism...making it the first oral anti-clotting drug approved for the treatment of blood clots since warfarin (Coumadin) almost 60 years ago.

A New gonadotropin.......

Submitted by sravani kompella on Wed, 11/16/2011 - 17:23

Hello bloggers, Recently when I was going on through an article found that in certain people, follicle stimulating gonadotrophin and interstitial cell-stimulating hormone of the anterior pituitary gland are supplemented. Let us see how they are being substituted...

Oral strip technology; an overview (audio blog)

Submitted by raja_picta1023 on Fri, 06/24/2011 - 03:51

Oral strip technology; an overview

Hello and welcome to my audio blog,
In this oral blog I present an overview on oral strip technology
[swf file="http://c450871.r71.cf2.rackcdn.com/OralstriptechnologyRajaPitchJulu2011.mp3"]

It includes following information
1)An introduction to novel drug delivery giving the importance of oral films…

Preclinical Studies in Drug Development

Submitted by gangadhar hari on Sun, 03/13/2011 - 10:15

Hi Friends, my first blog for this month is regarding Preclinical studies in Drug development. After its discovery in the laboratory every New Chemical Entity NCE)should face a series of challenges/trials to make its way into the market successfully. The entire drug development process can be divided into the following steps: [1] 1. Preclinical Studies/Trials